Skip to content
zameds

Rosuvastatin, ezetimibe (Rozumib)

Rosuvastatin, ezetimibe

Teva Pharmaceuticals (Pty) Ltd

Every registration of this product has been cancelled.

S4

Registration

Applicant
Teva Pharmaceuticals (Pty) Ltd
Registrations
4
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Rozumib 20/10

EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 20,0 mg & EZETIMIBE 10,0 mg

20/1055/7.5/0411CancelledS4None
Rozumib 5/10

EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 5,0 mg & EZETIMIBE 10,0 mg

5/1055040955/7.5/0409CancelledS4None
Rozumib 10/10

EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10,0 mg & EZETIMIBE 10,0 mg

10/1055041055/7.5/0410CancelledS4None
Rozumib 40/10

EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 40,0 mg & EZETIMIBE 10,0 mg

40/1055041255/7.5/0412CancelledS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence medium.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Rosuvastatin calcium equivalent to rosuvastatin, & ezetimibe

  • S4: Ezetimibe

    Consolidated Schedules 06 July 2026, line 6302

  • S4: Rosuvastatin

    Consolidated Schedules 06 July 2026, line 7853

Pharmacological class: Serum-cholesterol reducers. (class 7.5)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles